Index
Grant: Kainomyx — Antimalarial Drug (2021) (Coefficient Giving → Kainomyx)
Verdictconfirmed95%
1 check · 4/9/2026Deterministic match: grantee, amount, date matched in source snapshot (2714 rows)
Our claim
entire record- Name
- Kainomyx — Antimalarial Drug (2021)
- Amount
- $4,000,000
- Currency
- USD
- Date
- September 2021
- Notes
[Other Scientific Research Areas] Open Philanthropy recommended an investment of $4,000,000 in Kainomyx to develop and produce new drugs to treat malaria and other parasitic diseases, such as cryptosporidiosis and toxoplasmosis. If effective, the new drugs would act by inhibiting… expand
[Other Scientific Research Areas] Open Philanthropy recommended an investment of $4,000,000 in Kainomyx to develop and produce new drugs to treat malaria and other parasitic diseases, such as cryptosporidiosis and toxoplasmosis. If effective, the new drugs would act by inhibiting cytoskeletal proteins in malarial and other parasites. Our science team believes that there is a need for new antimalarial drugs due to increasing resistance to existing treatments. This follows our May 2020 investment and falls within our work on scientific research, specifically within our interest in advancing human health and wellbeing.
Source evidence
1 src · 1 checkconfirmed95%deterministic-row-match · 4/9/2026
- Name
- Kainomyx — Antimalarial Drug (2021)
- Grantee
- Kainomyx
- Focus Area
- Other Scientific Research Areas
- Amount
- $4,000,000.00
- Date
- September 2021
- Description
- Open Philanthropy recom
NoteDeterministic match: grantee, amount, date matched in source snapshot (2714 rows)
Case № 9DPzJrUZkmFiled 4/9/2026Confidence 95%